See appendix for full listing of The IHWG HCT members.
14th International HLA and Immunogenetics Workshop: Report on hematopoietic cell transplantation
Version of Record online: 13 APR 2007
2007 Blackwell Munksgaard
Volume 69, Issue Supplement s1, pages 17–24, April 2007
How to Cite
Petersdorf, E., Bardy, P., Cambon-Thomsen, A., Goulmy, E., Hansen, J., Schwarer, A., Velardi, A. and The IHWG HCT (2007), 14th International HLA and Immunogenetics Workshop: Report on hematopoietic cell transplantation. Tissue Antigens, 69: 17–24. doi: 10.1111/j.1399-0039.2006.759_1.x
- Issue online: 13 APR 2007
- Version of Record online: 13 APR 2007
- HLA matching;
- unrelated doner
Deciphering the role of human leukocyte antigen (HLA), killer immunoglobulin like receptor, and immune response genes in a model as complex as unrelated donor hematopoietic cell transplantation is a challenge. The allelic diversity of these genes is shaped by the race and ethnicity of transplant donors and recipients. Coupled with the genetic polymorphism is the complexity of clinical phenotypes of transplant populations: donor and recipient demographic characteristics and the regimens used by transplant physicians to prepare patients for transplantation and to prevent and treat graft-vs-host disease (GVHD). Furthermore, GVHD is itself a complex disease shaped by both genes and ‘environment’. How does one begin to deconstruct the genetic barrier to understand risk factors important to transplant outcome? To begin with, population-based studies, particularly retrospective ones, benefit from adequate sample sizes to measure genetic effects. The more homogeneous the population for variables that influence clinical endpoints, the higher the likelihood that a real genetic effect can be uncovered. Even so, the feasibility of studies can be hampered if genotype and clinical data are not both complete and precise. For studies of HLA, diversity of alleles and antigens contributed by ethnically different transplant populations is an asset, because not only can a broader range of HLA mismatches be studied but they provide the opportunity for side-by-side analyses that may yield clues as to why transplant outcomes differ between populations.